+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Infectious Respiratory Disease Diagnostics Market Size, Share & Trends Analysis By Product (Instruments, Services, Consumables), Sample (Blood, NPS), Application, Technology, End-use, Region, and Segment Forecasts, 2025-2030

  • PDF Icon

    Report

  • 120 Pages
  • October 2024
  • Region: Global
  • Grand View Research
  • ID: 5665116
Description Jump to:
The global infectious respiratory disease diagnostics market size is anticipated to reach USD 73.56 billion by 2030. The market is projected to grow at a CAGR of 5.3% from 2025 to 2030. The decline in market size is majorly attributed to the decline in COVID-19 testing. However, the market without the impact of COVID-19 is expected to grow over the forecast years. The growth can be attributed to an increase in the prevalence of infectious respiratory diseases and initiatives taken by governments & nonprofit organizations to introduce novel & innovative products to address the increasing demand. For instance, the global investment in tuberculosis R&D reached USD 915 million, and around USD 401 million was spent by the U.S. government on TB research in 2020.

During the forecast period, the global industry is expected to be driven by the rising incidence of infectious respiratory disorders, such as tuberculosis, RSV, and influenza. According to the UN, pneumonia affects around 4.2 million people every year. Key players are developing innovative techniques to improve production for meeting the growing demand in diagnostics and consumables for the diagnosis of infectious diseases. For instance, OPT Industries Inc. has introduced InstaSwab by utilizing the 3D printing system to address supply shortages of sample collection kits due to the COVID-19 pandemic. These swabs are made of woven lattices to absorb and release more fluid than conventional swabs. Companies are advancing their diagnosis products by using new techniques to gain target-specific and accurate results.

Canon Inc. announced the development of a built-in AEC assistance for digital X-rays in March 2021. The X-ray image sensor enables users to perform picture production and real-time detection of images corresponding to emitted X-rays. Furthermore, in May 2021, the University of California developed an ultrasensitive molecular test to identify the presence of SARS-CoV-2 and influenza A antigens using chip technology. In addition, companies are also launching multiplex tests for the simultaneous diagnosis of RSV, influenza, and COVID-19 respiratory diseases. RT-PCR tests are considered the gold standard for the diagnosis of COVID-19 in patients. However, high prices associated with molecular tests are one of the major factors impeding this market.

The lack of comparable products is another reason for hiked prices. This problem is further compounded by the significant variations in prices for different applications of each molecular diagnostic product. Companies are adopting strategies, such as new product launches and partnerships, to increase the penetration of infectious respiratory disease diagnostics products. For instance, in August 2021, Thermo Fisher Scientific Inc. received EUA for the introduction of two COVID-19 diagnostic products, TaqPath COVID-19 RNase P Combo Kit and TaqPath COVID-19 Fast PCR Combo Kit, in the U.S. market.

Infectious Respiratory Disease Diagnostics Market Report Highlights

  • The consumables segment dominated the market and accounted for the largest revenue share of 64.3% in 2024. Technological advancements in diagnostic devices have resulted in more sophisticated testing methods, necessitating specialized consumables.
  • The COVID-19 segment dominated the global market in 2024, accounting for 43.8% of the revenue. Increased COVID-19 variants, product approvals, and heightened research and development efforts drove this dominance.
  • North America infectious respiratory disease diagnostics market dominated the overall global market and accounted for 41.85% of revenue share in 2024.
  • Tuberculosis is expected to exhibit the fastest CAGR over the forecast period owing to increasing government focus and R&D funding for the development of diagnostics
  • Asia Pacific is expected to experience the fastest growth over the forecast period owing to an increase in penetration of IVD products, rise in disposable income, and high prevalence of tuberculosis in underdeveloped countries

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments
  • Competitive Landscape: Explore the market presence of key players worldwide
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

The leading players in the Infectious Respiratory Disease Diagnostics market include:

  • Abbott
  • Thermo Fisher Scientific, Inc.
  • Koninklijke Philips N.V.
  • F. Hoffmann-La Roche Ltd.
  • BD
  • bioMérieux SA
  • Bio-Rad Laboratories, Inc.
  • Quidel Corporation
  • Siemens Healthcare GmbH
  • Danaher
  • Qiagen


This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Segment Definitions
1.2.1. Technology
1.2.2. Sample
1.2.3. Product
1.2.4. End Use
1.2.5. Application
1.2.6. Regional Scope
1.2.7. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Regional outlook
2.4. Competitive Insights
Chapter 3. Infectious Respiratory Disease Diagnostics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. High Prevalence Of Infectious Respiratory Diseases Globally
3.2.1.2. Technological Advancement In Respiratory Disease Testing
3.2.1.3. Rising R&D Investments In Respiratory Disease Testing
3.2.2. Market Restraint Analysis
3.2.2.1. High Prices Of Diagnostic Products
3.2.2.2. Presence Of Ambiguous Regulatory Framework
3.3. Infectious Respiratory Disease Diagnostics Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
Chapter 4. Infectious Respiratory Disease Diagnostics Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Infectious Respiratory Disease Diagnostics Market: Product Movement Analysis
4.3. Infectious Respiratory Disease Diagnostics Market by Product Outlook (USD Million)
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5. Instruments
4.5.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.2. Imaging Tests
4.5.2.1. Imaging Tests Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.3. Respiratory Measurement Devices
4.5.3.1. Respiratory Measurement Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.4. Other Instruments
4.5.4.1. Other Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Consumables
4.6.1. Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Services
4.7.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Infectious Respiratory Disease Diagnostics Market: Sample Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Infectious Respiratory Disease Diagnostics Market: Sample Movement Analysis
5.3. Infectious Respiratory Disease Diagnostics Market by Sample Outlook (USD Million)
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5. Saliva
5.5.1. Saliva Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Nasopharyngeal Swabs
5.6.1. Nasopharyngeal Swabs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Anterior Nasal Region
5.7.1. Anterior Nasal Region Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8. Blood
5.8.1. Blood Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.9. Others
5.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Infectious Respiratory Disease Diagnostics Market: Technology Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Infectious Respiratory Disease Diagnostics Market: Technology Movement Analysis
6.3. Infectious Respiratory Disease Diagnostics Market by Technology Outlook (USD Million)
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5. Immunoassay
6.5.1. Immunoassay Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Molecular Diagnostics
6.6.1. Molecular Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Microbiology
6.7.1. Microbiology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8. Other Technologies
6.8.1. Other Technologies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Infectious Respiratory Disease Diagnostics Market: Application Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Infectious Respiratory Disease Diagnostics Market: Application Movement Analysis
7.3. Infectious Respiratory Disease Diagnostics Market by Application Outlook (USD Million)
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.5. COVID-19
7.5.1. COVID-19 Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Influenza
7.6.1. Influenza Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. Respiratory Syncytial Virus
7.7.1. Respiratory Syncytial Virus Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8. Tuberculosis
7.8.1. Tuberculosis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.9. Streptococcus Testing
7.9.1. Streptococcus Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.10. Other Respiratory Disease Testing
7.10.1. Other Respiratory Disease Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Infectious Respiratory Disease Diagnostics Market: End Use Estimates & Trend Analysis
8.1. Segment Dashboard
8.2. Infectious Respiratory Disease Diagnostics Market: End Use Movement Analysis
8.3. Infectious Respiratory Disease Diagnostics Market by End Use Outlook (USD Million)
8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
8.5. Hospitals
8.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6. Diagnostic Laboratories
8.6.1. Diagnostic Laboratories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.7. Pharmaceutical & Biotechnology Companies
8.7.1. Pharmaceutical & Biotechnology Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.8. Physician Offices
8.8.1. Physician Offices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.9. Other End-Users
8.9.1. Other End-Users Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 9. Infectious Respiratory Disease Diagnostics Market: Regional Estimates & Trend Analysis
9.1. Regional Dashboard
9.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
9.3. North America
9.3.1. U.S.
9.3.1.1. Key country dynamics
9.3.1.2. Regulatory framework/ reimbursement structure
9.3.1.3. Competitive scenario
9.3.1.4. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
9.3.2. Canada
9.3.2.1. Key country dynamics
9.3.2.2. Regulatory framework/ reimbursement structure
9.3.2.3. Competitive scenario
9.3.2.4. Canada market estimates and forecasts 2018 - 2030 (USD Million)
9.3.3. Mexico
9.3.3.1. Key country dynamics
9.3.3.2. Regulatory framework/ reimbursement structure
9.3.3.3. Competitive scenario
9.3.3.4. Mexico market estimates and forecasts 2018 - 2030 (USD Million)
9.4. Europe
9.4.1. UK
9.4.1.1. Key country dynamics
9.4.1.2. Regulatory framework/ reimbursement structure
9.4.1.3. Competitive scenario
9.4.1.4. UK market estimates and forecasts 2018 - 2030 (USD Million)
9.4.2. Germany
9.4.2.1. Key country dynamics
9.4.2.2. Regulatory framework/ reimbursement structure
9.4.2.3. Competitive scenario
9.4.2.4. Germany market estimates and forecasts 2018 - 2030 (USD Million)
9.4.3. France
9.4.3.1. Key country dynamics
9.4.3.2. Regulatory framework/ reimbursement structure
9.4.3.3. Competitive scenario
9.4.3.4. France market estimates and forecasts 2018 - 2030 (USD Million)
9.4.4. Italy
9.4.4.1. Key country dynamics
9.4.4.2. Regulatory framework/ reimbursement structure
9.4.4.3. Competitive scenario
9.4.4.4. Italy market estimates and forecasts 2018 - 2030 (USD Million)
9.4.5. Spain
9.4.5.1. Key country dynamics
9.4.5.2. Regulatory framework/ reimbursement structure
9.4.5.3. Competitive scenario
9.4.5.4. Spain market estimates and forecasts 2018 - 2030 (USD Million)
9.4.6. Norway
9.4.6.1. Key country dynamics
9.4.6.2. Regulatory framework/ reimbursement structure
9.4.6.3. Competitive scenario
9.4.6.4. Norway market estimates and forecasts 2018 - 2030 (USD Million)
9.4.7. Sweden
9.4.7.1. Key country dynamics
9.4.7.2. Regulatory framework/ reimbursement structure
9.4.7.3. Competitive scenario
9.4.7.4. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
9.4.8. Denmark
9.4.8.1. Key country dynamics
9.4.8.2. Regulatory framework/ reimbursement structure
9.4.8.3. Competitive scenario
9.4.8.4. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
9.5. Asia Pacific
9.5.1. Japan
9.5.1.1. Key country dynamics
9.5.1.2. Regulatory framework/ reimbursement structure
9.5.1.3. Competitive scenario
9.5.1.4. Japan market estimates and forecasts 2018 - 2030 (USD Million)
9.5.2. China
9.5.2.1. Key country dynamics
9.5.2.2. Regulatory framework/ reimbursement structure
9.5.2.3. Competitive scenario
9.5.2.4. China market estimates and forecasts 2018 - 2030 (USD Million)
9.5.3. India
9.5.3.1. Key country dynamics
9.5.3.2. Regulatory framework/ reimbursement structure
9.5.3.3. Competitive scenario
9.5.3.4. India market estimates and forecasts 2018 - 2030 (USD Million)
9.5.4. Australia
9.5.4.1. Key country dynamics
9.5.4.2. Regulatory framework/ reimbursement structure
9.5.4.3. Competitive scenario
9.5.4.4. Australia market estimates and forecasts 2018 - 2030 (USD Million)
9.5.5. South Korea
9.5.5.1. Key country dynamics
9.5.5.2. Regulatory framework/ reimbursement structure
9.5.5.3. Competitive scenario
9.5.5.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
9.5.6. Thailand
9.5.6.1. Key country dynamics
9.5.6.2. Regulatory framework/ reimbursement structure
9.5.6.3. Competitive scenario
9.5.6.4. Thailand market estimates and forecasts 2018 - 2030 (USD Million)
9.6. Latin America
9.6.1. Brazil
9.6.1.1. Key country dynamics
9.6.1.2. Regulatory framework/ reimbursement structure
9.6.1.3. Competitive scenario
9.6.1.4. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
9.6.2. Argentina
9.6.2.1. Key country dynamics
9.6.2.2. Regulatory framework/ reimbursement structure
9.6.2.3. Competitive scenario
9.6.2.4. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
9.7. MEA
9.7.1. South Africa
9.7.1.1. Key country dynamics
9.7.1.2. Regulatory framework/ reimbursement structure
9.7.1.3. Competitive scenario
9.7.1.4. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
9.7.2. Saudi Arabia
9.7.2.1. Key country dynamics
9.7.2.2. Regulatory framework/ reimbursement structure
9.7.2.3. Competitive scenario
9.7.2.4. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
9.7.3. UAE
9.7.3.1. Key country dynamics
9.7.3.2. Regulatory framework/ reimbursement structure
9.7.3.3. Competitive scenario
9.7.3.4. UAE market estimates and forecasts 2018 - 2030 (USD Million)
9.7.4. Kuwait
9.7.4.1. Key country dynamics
9.7.4.2. Regulatory framework/ reimbursement structure
9.7.4.3. Competitive scenario
9.7.4.4. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)
Chapter 10. Competitive Landscape
10.1. Market Participant Categorization
10.2. Recent Developments & Impact Analysis by Key Market Participants
10.3. Company Market Share Analysis, 2024
10.4. Key Company Profiles
10.4.1. ABBOTT
10.4.1.1. Company overview
10.4.1.2. Financial performance
10.4.1.3. Product benchmarking
10.4.1.4. Strategic initiatives
10.4.2. F. Hoffmann - La Roche Ltd
10.4.2.1. Company overview
10.4.2.2. Financial performance
10.4.2.3. Product benchmarking
10.4.2.4. Strategic initiatives
10.4.3. THERMO FISHER SCIENTIFIC, INC.
10.4.3.1. Company overview
10.4.3.2. Financial performance
10.4.3.3. Product benchmarking
10.4.3.4. Strategic initiatives
10.4.4. KONINKLIJKE PHILIPS N.V.
10.4.4.1. Company overview
10.4.4.2. Financial performance
10.4.4.3. Product benchmarking
10.4.4.4. Strategic initiatives
10.4.5. BIOMÉRIEUX SA
10.4.5.1. Company overview
10.4.5.2. Financial performance
10.4.5.3. Product benchmarking
10.4.5.4. Strategic initiatives
10.4.6. BIO-RAD LABORATORIES, INC.
10.4.6.1. Company overview
10.4.6.2. Financial performance
10.4.6.3. Product benchmarking
10.4.6.4. Strategic initiatives
10.4.7. QUIDEL CORPORATION
10.4.7.1. Company overview
10.4.7.2. Financial performance
10.4.7.3. Product benchmarking
10.4.7.4. Strategic initiatives
10.4.8. CEPHEID
10.4.8.1. Company overview
10.4.8.2. Financial performance
10.4.8.3. Product benchmarking
10.4.8.4. Strategic initiatives
10.4.9. QIAGEN
10.4.9.1. Company overview
10.4.9.2. Financial performance
10.4.9.3. Product benchmarking
10.4.9.4. Strategic initiatives
10.4.10. SIEMENS HEALTHCARE GMBH
10.4.10.1. Company overview
10.4.10.2. Financial performance
10.4.10.3. Product benchmarking
10.4.10.4. Strategic initiatives
List of Tables
Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. Global infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
Table 4. Global infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
Table 5. Global infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 6. Global infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
Table 7. Global infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 8. North America infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
Table 9. North America infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
Table 10. North America infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 11. North America infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
Table 12. North America infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 13. U.S. infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
Table 14. U.S. infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
Table 15. U.S. infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 16. U.S. infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
Table 17. U.S. infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 18. Canada infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
Table 19. Canada infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
Table 20. Canada infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 21. Canada infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
Table 22. Canada infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 23. Mexico infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
Table 24. Mexico infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
Table 25. Mexico infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 26. Mexico infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
Table 27. Mexico infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 28. Europe infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
Table 29. Europe infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
Table 30. Europe infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 31. Europe infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
Table 32. Europe infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 33. UK infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
Table 34. UK infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
Table 35. UK infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 36. UK infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
Table 37. UK infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 38. Germany infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
Table 39. Germany infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
Table 40. Germany infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 41. Germany infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
Table 42. Germany infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 43. France infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
Table 44. France infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
Table 45. France infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 46. France infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
Table 47. France infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 48. Italy infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
Table 49. Italy infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
Table 50. Italy infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 51. Italy infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
Table 52. Italy infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 53. Spain infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
Table 54. Spain infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
Table 55. Spain infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 56. Spain infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
Table 57. Spain infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 58. Denmark infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
Table 59. Denmark infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
Table 60. Denmark infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 61. Denmark infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
Table 62. Denmark infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 63. Sweden infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
Table 64. Sweden infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
Table 65. Sweden infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 66. Sweden infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
Table 67. Sweden infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 68. Norway infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
Table 69. Norway infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
Table 70. Norway infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 71. Norway infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
Table 72. Norway infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 73. Asia Pacific infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
Table 74. Asia Pacific infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
Table 75. Asia Pacific infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 76. Asia Pacific infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
Table 77. Asia Pacific infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 78. Japan infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
Table 79. Japan infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
Table 80. Japan infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 81. Japan infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
Table 82. Japan infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 83. China infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
Table 84. China infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
Table 85. China infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 86. China infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
Table 87. China infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 88. India infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
Table 89. India infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
Table 90. India infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 91. India infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
Table 92. India infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 93. Australia infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
Table 94. Australia infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
Table 95. Australia infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 96. Australia infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
Table 97. Australia infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 98. South Korea infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
Table 99. South Korea infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
Table 100. South Korea infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 101. South Korea infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
Table 102. South Korea infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 103. Thailand infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
Table 104. Thailand infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
Table 105. Thailand infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 106. Thailand infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
Table 107. Thailand infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 108. Latin America infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
Table 109. Latin America infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
Table 110. Latin America infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 111. Latin America infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
Table 112. Latin America infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 113. Brazil infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
Table 114. Brazil infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
Table 115. Brazil infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 116. Brazil infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
Table 117. Brazil infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 118. Argentina infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
Table 119. Argentina infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
Table 120. Argentina infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 121. Argentina infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
Table 122. Argentina infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 123. Middle East & Africa infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
Table 124. Middle East & Africa infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
Table 125. Middle East & Africa infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 126. Middle East & Africa infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
Table 127. Middle East & Africa infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 128. South Africa infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
Table 129. South Africa infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
Table 130. South Africa infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 131. South Africa infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
Table 132. South Africa infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 133. Saudi Arabia infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
Table 134. Saudi Arabia infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
Table 135. Saudi Arabia infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 136. Saudi Arabia infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
Table 137. Saudi Arabia infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 138. UAE infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
Table 139. UAE infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
Table 140. UAE infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 141. UAE infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
Table 142. UAE infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 143. Kuwait infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
Table 144. Kuwait infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
Table 145. Kuwait infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 146. Kuwait infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
Table 147. Kuwait infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Information procurement
Fig. 2 Primary research pattern
Fig. 3 Market research approaches
Fig. 4 Value chain-based sizing & forecasting
Fig. 5 Market formulation & validation
Fig. 6 Infectious respiratory disease diagnostics market segmentation
Fig. 7 Market driver analysis (current & future impact)
Fig. 8 Market restraint analysis (current & future impact)
Fig. 9 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 10 Porter’s five forces analysis
Fig. 11 Infectious respiratory disease diagnostics market, Product outlook key takeaways 2024 & 2030 (USD Million)
Fig. 12 Infectious respiratory disease diagnostics market, Sample outlook key takeaways 2024 & 2030 (USD Million)
Fig. 13 Infectious respiratory disease diagnostics market, Technology outlook key takeaways 2024 & 2030 (USD Million)
Fig. 14 Infectious respiratory disease diagnostics market, Application outlook key takeaways 2024 & 2030 (USD Million)
Fig. 15 Infectious respiratory disease diagnostics market, End Use outlook key takeaways 2024 & 2030 (USD Million)
Fig. 16 Instruments market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 17 Imaging Tests market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 18 Respiratory Measurement Devices market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 19 Other Instruments market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Consumables market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Services market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Saliva market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Nasopharyngeal Swabs market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Anterior Nasal Region market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Blood market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Immunoassay market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Molecular Diagnostics market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Microbiology market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Other Technologies market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 COVID-19 market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Influenza market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Respiratory Syncytial Virus market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Tuberculosis market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Streptococcus Testing market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Other Respiratory Disease Testing market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Hospitals market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Diagnostic Laboratories market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Physician Offices market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Other End users market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 North America infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 U.S. infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Canada infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Mexico infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Europe infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 UK infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Germany infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 France infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Spain infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Italy infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Norway infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Denmark infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Sweden infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Asia Pacific infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 China infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Japan infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 India infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 South Korea infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Australia infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 Thailand infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Latin America infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 Brazil infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Argentina infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 Middle East and Africa infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 South Africa infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 66 Saudi Arabia infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 UAE infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 Kuwait infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 List of key emerging company’s/Allergen disruptors/innovators

Companies Mentioned

  • Abbott
  • Thermo Fisher Scientific, Inc.
  • Koninklijke Philips N.V.
  • F. Hoffmann-La Roche Ltd.
  • BD
  • bioMérieux SA
  • Bio-Rad Laboratories, Inc.
  • Quidel Corporation
  • Siemens Healthcare GmbH
  • Danaher
  • Qiagen

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages120
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 54.58 Billion
Forecasted Market Value ( USD ) by 2030 $ 73.56 Billion
Compound Annual Growth Rate5.3%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

2024-2029 Global Respiratory Diseases Diagnostic Market: US, Europe, Japan - Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities - Product Image

2024-2029 Global Respiratory Diseases Diagnostic Market: US, Europe, Japan - Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

  • Report
  • Europe, Global, Japan, ... Europe, Global, Japan, United States
From
Respiratory Infection Diagnostics Market by Test, Disease, End-User - Global Forecast 2025-2030 - Product Image

Respiratory Infection Diagnostics Market by Test, Disease, End-User - Global Forecast 2025-2030

  • Report
  • 186 Pages
  • Global
From
Diagnostic Enzymes Market Size, Share & Trends Analysis Report by Type (Taq Polymerase, MMLV RT, HIV RT), Application (Diabetes, Oncology, Cardiology), Product, End-use, Region, and Segment Forecasts, 2025-2030 - Product Image

Diagnostic Enzymes Market Size, Share & Trends Analysis Report by Type (Taq Polymerase, MMLV RT, HIV RT), Application (Diabetes, Oncology, Cardiology), Product, End-use, Region, and Segment Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From
DNA Diagnostics Market Size, Share & Trends Analysis Report By Technology (PCR-based Diagnostics, NGS DNA Diagnosis), By Application (Cancer Genetics Tests, Infectious Diseases DNA Testing), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

DNA Diagnostics Market Size, Share & Trends Analysis Report By Technology (PCR-based Diagnostics, NGS DNA Diagnosis), By Application (Cancer Genetics Tests, Infectious Diseases DNA Testing), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From
Acute Care Syndromic Testing Market by Disease Type, Target, Sample Type, End User - Global Forecast 2025-2030 - Product Image

Acute Care Syndromic Testing Market by Disease Type, Target, Sample Type, End User - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From

About the Infectious Respiratory Disease Diagnostics Market

The Infectious Respiratory Disease Diagnostics market is a subset of the Diagnostics industry, focusing on the detection and diagnosis of infectious respiratory diseases. These diseases can be caused by a variety of pathogens, including bacteria, viruses, and fungi. Diagnostics in this market are used to identify the presence of a pathogen, as well as to determine the severity of the infection. Diagnostics can also be used to monitor the progress of the infection and to determine the effectiveness of treatment. Diagnostics in this market are used in both clinical and research settings. Companies in this market include Abbott, Becton Dickinson, Cepheid, Hologic, and Roche. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.